Literature DB >> 7814494

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix.

J Schachter1, W E Stamm, T C Quinn, W W Andrews, J D Burczak, H H Lee.   

Abstract

We performed a multicenter evaluation of ligase chain reaction (LCR) in the diagnosis of Chlamydia trachomatis infection of the cervix. This LCR provides an amplification of target sequences within the chlamydial cryptic plasmid. The LCR results were compared with those of isolation in cell culture. Discrepant (tissue culture-negative and LCR-positive) test results were resolved by the application of a direct immunofluorescent-antibody test to detect chlamydial elementary bodies and by the use of alternate DNA primers that targeted the chlamydial major outer membrane protein gene. A total of 234 of 2,132 specimens (10.9%) could be confirmed as containing C. trachomatis. Of these, 152 were detected by isolation in cell culture and 221 were detected by LCR. The corresponding sensitivities were 94% for LCR and 65% for cell culture. There was greater variability among study site results for cell culture sensitivity (52 to 92%) than for LCR sensitivity (87 to 98%). The specificity of each test was greater than 99.9%. Thus, LCR offers a highly sensitive nonculture method for detecting chlamydial infection of the cervix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814494      PMCID: PMC264098          DOI: 10.1128/jcm.32.10.2540-2543.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Rapid diagnosis of sexually transmitted diseases--speed has a price.

Authors:  J Schachter
Journal:  Diagn Microbiol Infect Dis       Date:  1986-03       Impact factor: 2.803

2.  Why we need a program for the control of Chlamydia trachomatis.

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1989-03-23       Impact factor: 91.245

3.  Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection.

Authors:  K A Workowski; M F Lampe; K G Wong; M B Watts; W E Stamm
Journal:  JAMA       Date:  1993-11-03       Impact factor: 56.272

4.  Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population.

Authors:  L M Clarke; M F Sierra; B J Daidone; N Lopez; J M Covino; W M McCormack
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

5.  A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.

Authors:  D H Martin; T F Mroczkowski; Z A Dalu; J McCarty; R B Jones; S J Hopkins; R B Johnson
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

Review 6.  Diagnosis of Chlamydia trachomatis genitourinary infections.

Authors:  W E Stamm
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

7.  Diagnosis of Chlamydia trachomatis urethritis in men by polymerase chain reaction assay of first-catch urine.

Authors:  J E Bauwens; A M Clark; M J Loeffelholz; S A Herman; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Diagnosis of Chlamydia trachomatis endocervical infections by a commercial polymerase chain reaction assay.

Authors:  J E Bauwens; A M Clark; W E Stamm
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization.

Authors:  R S Stephens; M R Tam; C C Kuo; R C Nowinski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay.

Authors:  G Jaschek; C A Gaydos; L E Welsh; T C Quinn
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

View more
  60 in total

1.  Evaluation of the NucliSens Basic Kit for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genital tract specimens using nucleic acid sequence-based amplification of 16S rRNA.

Authors:  J B Mahony; X Song; S Chong; M Faught; T Salonga; J Kapala
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Evaluation of laboratory testing methods for Chlamydia trachomatis infection in the era of nucleic acid amplification.

Authors:  T J Battle; M R Golden; K L Suchland; J M Counts; J P Hughes; W E Stamm; K K Holmes
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Evaluation of a commercial ligase chain reaction kit (Abbott LCx) for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens.

Authors:  E Tortoli; F Lavinia; M T Simonetti
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Chlamydia trachomatis diagnostics.

Authors:  M A Chernesky
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

5.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens.

Authors:  Lisa A Cosentino; Daniel V Landers; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model.

Authors:  Daniel H Farkas; Nicholas E Miltgen; Jay Stoerker; Dirk van den Boom; W Edward Highsmith; Lesley Cagasan; Ron McCullough; Reinhold Mueller; Lin Tang; John Tynan; Courtney Tate; Allan Bombard
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

7.  Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine.

Authors:  W H Goessens; J W Mouton; W I van der Meijden; S Deelen; T H van Rijsoort-Vos; N Lemmens-den Toom; H A Verbrugh; R P Verkooyen
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

8.  Evaluation of an automated liquid-handling system (Tecan Genesis RSP 100) in the Abbott LCx assay for Chlamydia trachomatis.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 9.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population.

Authors:  K C Carroll; W E Aldeen; M Morrison; R Anderson; D Lee; S Mottice
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.